Imunon (FRA:CBO0) Current Deferred Taxes Liabilities: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CBO0 Imunon Inc FRA:CBO0
37 GF Score
Price €1.25
GF Value €5.35
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Imunon Current Deferred Taxes Liabilities?

Imunon FRA:CBO0 +0.81% 37 Current Deferred Taxes Liabilities is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:CBO0 with a GF Score™ of 37/100 and a GF Value™ of €5.35 (Possible Value Trap). The stock has 3 warning signs investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Imunon's current deferred tax liabilities for the quarter that ended in Jun. 2026 was €0.00 Mil.

Imunon Current Deferred Taxes Liabilities Related Terms

Imunon Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Imunon's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imunon Current Deferred Taxes Liabilities Chart

Imunon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imunon Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CBO0
37GF Score
Imunon Inc FRA:CBO0
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of €0.00 Mil mean?
Imunon (FRA:CBO0) has a Current Deferred Taxes Liabilities of €0.00 Mil as of Jun. 2026. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Imunon and its competitors.
Is Imunon's Current Deferred Taxes Liabilities too high?
Imunon's current Current Deferred Taxes Liabilities is €0.00 Mil. Overall, Imunon has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Imunon's Current Deferred Taxes Liabilities compare to TRAW and OSRH?
Imunon's Current Deferred Taxes Liabilities of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Biotechnology company?
A good Current Deferred Taxes Liabilities depends on the Biotechnology industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Imunon and its competitors. Imunon's current Current Deferred Taxes Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imunon stock overvalued right now?
Based on GuruFocus' analysis, Imunon (FRA:CBO0) is currently considered Possible Value Trap. The stock's GF Value™ is €5.35, compared to a current price of €1.25 — trading 76.6% below its estimated fair value. The current Current Deferred Taxes Liabilities is €0.00 Mil. Imunon's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Imunon (FRA:CBO0), the current Current Deferred Taxes Liabilities is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imunon (FRA:CBO0) Overvalued in 2026?

Based on GuruFocus' analysis, Imunon stock appears to be undervalued. The current stock price of €1.25 is trading 76.6% below its estimated GF Value™ of €5.35. GuruFocus considers Imunon to be Possible Value Trap.

Key valuation signals for FRA:CBO0:

  • Current Deferred Taxes Liabilities: €0.00 Mil
  • GF Value™: €5.35 vs. price of €1.25 (76.6% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the FRA:CBO0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imunon Business Description

Other Exchanges IMNN:USACBO0:Germany
Address 997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
37GF Score

Get the complete analysis for FRA:CBO0

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.25
Price
€5.35
GF Value